期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

精神分裂症与2型糖尿病相关问题的研究进展 被引量：14

下载PDF
导出
摘要 本文对近年来有关精神分裂症、抗精神病药物与2型糖尿病之间相关问题研究的进展进行了综述。
作者 秦峰 郑洪波 马崔
机构地区 广州医学院附属广州市精神病医院
出处 《国际精神病学杂志》 2005年第4期206-209,共4页 Journal Of International Psychiatry
关键词 精神分裂症 2型糖尿病 抗精神病药物
分类号 R749.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献15

  • 1Adams PR, Mara~o MA. Current Estimates from the National Health interview Survey (1994), Vital and Health Statistics Series 10, Number 193. DHHS Publication PHS 96-1521.Hysttscille, MD: National Center for Health Statistic.
  • 2Dixon L, Weiden P, Delahanty J. et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin. 2000; 26: 903-912.
  • 3Seryak MJ, Leslie DR, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuoleptics in the treatment of schizophrenia. American Journal of Psychiatry . 2002; 159:561-566.
  • 4Subramaniam M, Chong SA& Pek E. Diabetes mellitus and impaired glucose tolerance in patient with schizophrenia. Canadian Journal of Psychiatry. 2003 ; 48 : 345-347.
  • 5Lamberti J, Crilly J, Maharaj K, et al. Prevalence of adult-onset diabetes among outpatients receiving antipsychotic drugs.Schizophrenia Rese arch. 2003; 60 (suppl): s360.
  • 6Ryan MC, Collins P, Thakore JH . Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.Am J Psychiatry. 2003; 160 (2) : 284-9.
  • 7Knower W. C, Barrett-Connor E, Fowler S. E et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England journal of Medicine. 2002; 346:393-403.
  • 8Ryan MC & Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Science. 2002;71 : 239-257.
  • 9Thakore JH, Vlahoos J & Martine A. Increased visceral fat distribution in drug naive and drug-free patients with schizophrenia.Intemational Journal of Obesity Related Metabolic Disorder.2002; 26: 137-141.
  • 10Eniz G, Gasparo M, Biondetti PR, et al. Subcutaneous and visceral fat distribution according to age, sex and overweight,evaluated by computed tomography. American Journal of Clinical Nutrition. 1986; 44: 739-746.

二级参考文献14

  • 1Sernyak M J, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with use of atypical neuroleptic in the treatment of schizophrenia. Am J Psychiatry, 2002,159 (4): 561-566.
  • 2H agg S, Joelsson L, Mj Ondal T, et al. Prevalence of diabetes and impaired glucosetolerance in patients with conventional depot neuroleptic medications. J Clin Psychiatry, 1998, 59 (6): 294-29.
  • 3Atmaca M, kuloglu M, Tezcan E, et al. Serum leptin and triglcerffe levels in patients on treatment with atypical antipsycchotics. J Clin Psychiatry, 2003; 64 (5): 598-604.
  • 4Heiskanen T, Niskanen L, Lyytik R, et al. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry, 2003,64 (5): 575-579.
  • 5Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scan. 2003,108: 208-214.
  • 6Zhang Y, Proenca R, Maffei M, et al. Positional Cloning of the mouse obese gene and its human homologue. Nature, 1994, 372: 425-432.
  • 7Halaas JL, Gajiwala KS, Mallei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene.Science, 1995; 269: 543-6.
  • 8Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Molecular Endocrinology, 1997, 11 (4) :393-399.
  • 9Seufert J. Leptin effects on pancreatic beta-cell gene expresssion and function. Diabetes, 2004, 53 suppl: s 152-158.
  • 10Shojima N, Sakoda H, Ogihara T, et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes, 2002, 51: 1737-44.

共引文献4

同被引文献98

引证文献14

二级引证文献89

国际精神病学杂志
2005年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部